IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants
IDEAYA Biosciences priced a $300 million public offering consisting of 5.56 million shares of common stock and 5.56 million pre-funded warrants. The common stock was sold at $27.00 per share, while the pre-funded warrants were sold at $26.9999, effectively raising capital with minimal additional dilution compared to a pure equity offering. The company granted underwriters a 30-day option to purchase up to 1.67 million additional shares, potentially increasing total proceeds to ~$345 million.
Key figures
- Deal Value Usd
- 300000000
- Offering Price
- 27
- Overallotment shares
- 1666669
- Common shares offered
- 5555556
- Prefunded warrant price
- 26.9999
- Prefunded warrants offered
- 5555576
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.